Application of Instrumental Variables Method in Pharmacoepidemiology: An Example of Beta2-Agonist Use and Myocardial Infarction

被引：0
|
作者：
Uddin, M. Jamal [1 ]
Groenwold, Rolf H. H. [1 ,2 ]
de Boer, Anthonius [1 ]
Belitser, Svetlana V. [1 ]
Hoes, Arno W. [2 ]
Roes, Kit C. B. [2 ]
Klungel, Olaf H. [1 ,2 ]
机构：
[1] Univ Utrecht, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
61
引用
收藏
页码：32 / 33
页数：2
相关论文
共 29 条
  • [1] Evaluating Different Physician's Prescribing Preference Based Instrumental Variables in the Study of Beta2-Agonist Use and the Risk of Acute Myocardial Infarction
    Uddin, Md Jamal
    Groenwold, Rolf H. H.
    de Boer, Anthonius
    Afonso, Ana
    Primatesta, Paola
    Becker, Claudia
    Belitser, Svetlana V.
    Hoes, Arno W.
    Roes, Kit C. B.
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 32 - 32
  • [2] Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction
    Uddin, Md. Jamal
    Groenwold, Rolf H. H.
    de Boer, Anthonius
    Afonso, Ana S. M.
    Primatesta, Paola
    Becker, Claudia
    Belitser, Svetlana V.
    Hoes, Arno W.
    Roes, Kit C. B.
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 132 - 141
  • [3] AN INVESTIGATION OF THE CLINICAL IMPACT OF BETA2-AGONIST USE IN HEART FAILURE
    Bermingham, M.
    O'Callaghan, E.
    Dawkins, I
    Miwa, S.
    Samsudin, S.
    McDonald, K.
    Ledwidge, M.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S388 - S388
  • [4] Beta-agonist MDI use and the risk of myocardial infarction
    Au, DH
    Lemaitre, RN
    Curtis, JR
    Smith, NL
    Psaty, BM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A523 - A523
  • [5] Balance Measures for Propensity Score Methods: A Clinical Example on Beta-Agonist Use and the Risk of Myocardial Infarction
    Groenwold, Rolf H. H.
    de Vries, Frank
    de Boer, Anthonius
    Pestman, Wiebe R.
    Rutten, Frans H.
    Hoes, Arno W.
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S310 - S310
  • [6] Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction
    Groenwold, Rolf H. H.
    de Vries, Frank
    de Boer, Anthonius
    Pestman, Wiebe R.
    Rutten, Frans H.
    Hoes, Arno W.
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (11) : 1130 - 1137
  • [7] Time-dependent propensity score and collider-stratification bias: an example of beta2-agonist use and the risk of coronary heart disease
    Ali, M. Sanni
    Groenwold, Rolf H. H.
    Pestman, Wiebe R.
    Belitser, Svetlana V.
    Hoes, Arno W.
    de Boer, A.
    Klungel, Olaf H.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2013, 28 (04) : 291 - 299
  • [8] Developing a Smartphone Application That Promotes Responsible Short-Acting Beta2-Agonist Use in People with Asthma: A Participatory Design
    van den Berg, Liselot N.
    Hallensleben, Cynthia
    Chavannes, Niels H.
    Versluis, Anke
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (14)
  • [9] Time-dependent propensity score and collider-stratification bias: an example of beta2-agonist use and the risk of coronary heart disease
    M. Sanni Ali
    Rolf H. H. Groenwold
    Wiebe R. Pestman
    Svetlana V. Belitser
    Arno W. Hoes
    A. de Boer
    Olaf H. Klungel
    [J]. European Journal of Epidemiology, 2013, 28 : 291 - 299
  • [10] EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATENTS ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE
    Lanz, Miguel J.
    Pollack, Michael
    Gilbert, Ileen
    Gandhi, Hitesh N.
    Tkacz, Joseph
    Lugogo, Njira L.
    [J]. CHEST, 2022, 162 (04) : 48A - 49A
123